US Map / Colorado
State CO

Clinical Trials in Colorado

Colorado is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Colorado and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 268 actively recruiting studies with Colorado sites out of 268 registered in total. The busiest research areas in Colorado are Breast Cancer, Colorectal Cancer, Aging. Leading sponsors running trials in the state include University of Colorado, Denver, National Cancer Institute (NCI), Merck Sharp & Dohme LLC. By stage, Colorado trials break down as Phase 1 (38), Phase 2 (60), Phase 3 (75), Phase 4 (9).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
268
Recruiting Now
268
← Back to US Map
Top Conditions in Colorado
Breast Cancer (11)Colorectal Cancer (6)Aging (5)Metastatic Breast Cancer (4)Ovarian Cancer (4)Gastric Cancer (4)Esophageal Adenocarcinoma (4)Prostate Cancer (4)Surgery (3)Colorectal Carcinoma (3)Ovarian Carcinoma (3)Colon Cancer (3)

Frequently Asked Questions — Clinical Trials in Colorado

How many clinical trials are currently recruiting in Colorado?
ClinicalMetric currently tracks 268 actively recruiting clinical trials with at least one location in Colorado. The total number of registered studies—including active but not currently enrolling trials—is 268. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Colorado?
Colorado hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Colorectal Cancer, Aging, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Colorado serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Colorado?
To join a clinical trial in Colorado, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Colorado maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Colorado

NCT06627504 N/A
Recruiting
Type 1 Diabetes REst for Metabolic Health
Condition
Type 1 Diabetes (T1D)
Enrollment
50 pts
Location
United States
Sponsor
University of Colorado, Denver
View Trial →
NCT06982521 Phase 3
Recruiting
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatme...
Condition
PIK3CA Mutation
Enrollment
540 pts
Location
United States, Argentina, Australia
Sponsor
Relay Therapeutics, Inc.
View Trial →
NCT04853251 Phase 4
Recruiting
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age...
Condition
Neovascular Age-related Macular Degeneration
Enrollment
188 pts
Location
United States
Sponsor
Genentech, Inc.
View Trial →
NCT02315729 N/A
Recruiting
Analysis of Prognostic Cell Signaling Factors in Adolescent Idiopathic Scoliosis
Condition
Adolescent Idiopathic Scoliosis
Enrollment
380 pts
Location
United States
Sponsor
University of Colorado, Denver
View Trial →
NCT06838676 Phase 2
Recruiting
ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered ...
Condition
Diffuse Intrinsic Pontine Gliomas (DIPG)
Enrollment
60 pts
Location
United States, Australia, Canada
Sponsor
Nationwide Children's Hospital
View Trial →
NCT06710548 N/A
Recruiting
REVITALIZE: RCT to Reduce Fatigue in Adults With Ovarian Cancer on PARP Inhibito...
Condition
Ovarian Cancer
Enrollment
240 pts
Location
United States
Sponsor
Dana-Farber Cancer Institute
View Trial →
NCT07038343 Phase 1, Phase 2
Recruiting
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in P...
Condition
Solid Tumor Cancer
Enrollment
480 pts
Location
United States
Sponsor
Avenzo Therapeutics, Inc.
View Trial →
NCT04830137 Phase 1
Recruiting
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Condition
Chronic Lymphocytic Leukemia (CLL)
Enrollment
248 pts
Location
United States
Sponsor
Nurix Therapeutics, Inc.
View Trial →
NCT06289686 Phase 4
Recruiting
Rotator Cuff Repairs With or Without BioEnthesis™ Augmentation
Condition
Rotator Cuff Tears
Enrollment
100 pts
Location
United States
Sponsor
Brooke Army Medical Center
View Trial →
NCT04276922 N/A
Recruiting
Creative Arts Program to Reduce Burnout in Healthcare Professionals
Condition
Burn-Out Syndrome
Enrollment
195 pts
Location
United States
Sponsor
University of Colorado, Denver
View Trial →
NCT06133972 Phase 3
Recruiting
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participant...
Condition
Systemic Lupus Erythematosus
Enrollment
550 pts
Location
United States, Argentina, Australia
Sponsor
Novartis Pharmaceuticals
View Trial →
NCT07089875 Phase 3
Recruiting
A Study of Dotinurad Versus Allopurinol in Participants With Gout
Condition
Gout
Enrollment
500 pts
Location
United States, Poland, Spain
Sponsor
Crystalys Therapeutics
View Trial →
NCT06779773 N/A
Recruiting
A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice ...
Condition
Geographic Atrophy
Enrollment
500 pts
Location
United States
Sponsor
Astellas Pharma Global Develop
View Trial →
NCT06995898 N/A
Recruiting
The Vanguard Study: Testing a New Way to Screen for Cancer
Condition
Bladder Carcinoma
Enrollment
24,000 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT07705334 Phase 1
Recruiting
A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Me...
Condition
Advanced or Metastatic Solid Tumors
Enrollment
30 pts
Location
United States
Sponsor
SHY Therapeutics
View Trial →
NCT04375800 Phase 2
Recruiting
Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Aged 4 ...
Condition
Human Immunodeficiency Virus (HIV) Infection
Enrollment
84 pts
Location
United States, Colombia, Mexico
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT06990867 Phase 2, Phase 3
Recruiting
Optimizing Reperfusion to Improve Outcomes and Neurologic Function
Condition
Acute Ischemic Stroke
Enrollment
740 pts
Location
United States, Belgium, Bulgaria
Sponsor
Corxel Pharmaceuticals
View Trial →
NCT02734277 N/A
Recruiting
Type 1 Diabetes Extension Study
Condition
Type 1 Diabetes Mellitus
Enrollment
111 pts
Location
United States
Sponsor
National Institute of Allergy
View Trial →
NCT00900419 N/A
Recruiting
Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and...
Condition
Esophageal Cancer
Enrollment
700 pts
Location
United States
Sponsor
University of Colorado, Denver
View Trial →
NCT06544265 Phase 1
Recruiting
SynKIR-310 for Relapsed/Refractory B-NHL
Condition
B Cell Lymphoma
Enrollment
36 pts
Location
United States
Sponsor
Verismo Therapeutics
View Trial →
NCT07339111 Phase 3
Recruiting
Phase 3 Pivotal Trial Comparing CARTISTEM® and Surgical Comparator for Knee Cart...
Condition
Knee Cartilage Defects
Enrollment
300 pts
Location
United States
Sponsor
Medipost, Inc.
View Trial →
NCT06616194 Phase 3
Recruiting
A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With ...
Condition
Migraine
Enrollment
200 pts
Location
United States, Canada, China
Sponsor
Pfizer
View Trial →
NCT06563895 Phase 3
Recruiting
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) S...
Condition
Amyloidosis
Enrollment
587 pts
Location
United States, Argentina, Australia
Sponsor
Eidos Therapeutics, a BridgeBi
View Trial →
NCT07125183 Phase 2
Recruiting
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients Wit...
Condition
Sarcoma
Enrollment
20 pts
Location
United States
Sponsor
University of Colorado, Denver
View Trial →
NCT07309445 N/A
Recruiting
A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With N...
Condition
Non-Muscle Invasive Bladder Neoplasms
Enrollment
150 pts
Location
United States
Sponsor
Janssen Research & Development
View Trial →
Page 1 of 11 — 268 trials total
Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology